6-3015626-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000904.6(NQO2):c.400G>A(p.Asp134Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000904.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NQO2 | NM_000904.6 | c.400G>A | p.Asp134Asn | missense_variant | 5/7 | ENST00000380455.11 | NP_000895.2 | |
NQO2 | NM_001290221.2 | c.400G>A | p.Asp134Asn | missense_variant | 8/10 | NP_001277150.1 | ||
NQO2 | NM_001318940.2 | c.400G>A | p.Asp134Asn | missense_variant | 5/7 | NP_001305869.1 | ||
NQO2 | NM_001290222.2 | c.304-1258G>A | intron_variant | NP_001277151.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NQO2 | ENST00000380455.11 | c.400G>A | p.Asp134Asn | missense_variant | 5/7 | 1 | NM_000904.6 | ENSP00000369822 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251348Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135874
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461834Hom.: 0 Cov.: 34 AF XY: 0.0000248 AC XY: 18AN XY: 727236
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2023 | The c.400G>A (p.D134N) alteration is located in exon 5 (coding exon 4) of the NQO2 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the aspartic acid (D) at amino acid position 134 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at